REGENERON PHARMACEUTICALS, INC.
Position in NTLA — Intellia Therapeutics, Inc.
CIK 872589
TARRYTOWN, NY
Position in NTLA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$62,654,675
+$15,182,280 QoQ
Shares Held
3,702,995
0.0% QoQ
Ownership
2.64%
of shares outstanding
% of Portfolio
35.35%
of 13F equity value
Holder Rank
#10
of 330 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026REGENERON PHARMACEUTICALS, INC. holds $177,219,138 across 3 Biotechnology names. NTLA ranks #2 (35.4% of the industry book) .
All Filings in NTLA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,654,675 | 3,702,995 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $47,472,395 | 3,702,995 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $33,289,925 | 3,702,995 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $63,950,723 | 3,702,995 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $34,734,093 | 3,702,995 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $26,328,294 | 3,702,995 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $43,176,921 | 3,702,995 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||